Ajanta Pharma Limited (AJANTPHARM.NS) NSE

Currency In INR

AD

Valuation

Market Cap350.43B
Enterprise Value351.98B
P/E Ratio37.73
PEG Ratio2.5
Price/Sales Ratio7.31
Price/Book Ratio8.8
Enterprise/Revenue7.34
Enterprise/EBITDA25.53

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.19
Operating Margin0.45
AD

Management Effectiveness

Return On Assets0.17
Return On Equity0.26

Income Statement

Revenue54.53B
Revenue/Share436.52
Gross Profit28.05B
EBITDA15.67B
Net Income10.56B
Diluted EPS84.53

Balance Sheet

Total Cash6.65B
Total Cash/Share53.2
Total Debt2.6B
Total Debt/Equity0.06
Current Ratio2.64
Book Value Per Share362.4

Price History

52-Week Change24.36
52-Week High3,314.9
52-Week Low2,329.9
Moving Average 50 Days2,987.42
Moving Average 200 Days2,764.36

Statistics

Average Volume120,809
Shares Outstanding124.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate28
Trailing Annual Dividend Yield0.88
Payout Ratio0
Last Split Factor3:2
Last Split DateJune 22, 2022
AD